NRX Accounts Payable from 2010 to 2025
| NRXP Stock | USD 2.01 0.06 2.90% |
Accounts Payable | First Reported 2017-09-30 | Previous Quarter 4.9 M | Current Value 4.1 M | Quarterly Volatility 2.1 M |
Check NRX Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRX Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 41.8 K, Interest Expense of 218.5 K or Selling General Administrative of 19.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRX financial statements analysis is a perfect complement when working with NRX Pharmaceuticals Valuation or Volatility modules.
NRX | Accounts Payable |
Latest NRX Pharmaceuticals' Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of NRX Pharmaceuticals over the last few years. An accounting item on the balance sheet that represents NRX Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of NRX Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. NRX Pharmaceuticals' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRX Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
NRX Accounts Payable Regression Statistics
| Arithmetic Mean | 1,383,798 | |
| Geometric Mean | 426,454 | |
| Coefficient Of Variation | 122.71 | |
| Mean Deviation | 1,497,384 | |
| Median | 551,099 | |
| Standard Deviation | 1,698,020 | |
| Sample Variance | 2.9T | |
| Range | 4.5M | |
| R-Value | 0.83 | |
| Mean Square Error | 969.6B | |
| R-Squared | 0.69 | |
| Significance | 0.000074 | |
| Slope | 295,432 | |
| Total Sum of Squares | 43.2T |
NRX Accounts Payable History
About NRX Pharmaceuticals Financial Statements
NRX Pharmaceuticals shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although NRX Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in NRX Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on NRX Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 4.1 M | 2.6 M |
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.